Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $514.57 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $155.49 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $125.00 | 1 | $0 (2021) |
| Cook Incorporated | $109.56 | 1 | $0 (2017) |
| Nalu Medical, Inc. | $67.73 | 1 | $0 (2022) |
| Bioventus LLC | $44.03 | 1 | $0 (2022) |
| Merz North America, Inc. | $12.76 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $39.70 | 1 | Boston Scientific Corporation ($39.70) |
| 2022 | $130.64 | 3 | Nalu Medical, Inc. ($67.73) |
| 2021 | $221.91 | 2 | GlaxoSmithKline, LLC. ($125.00) |
| 2019 | $12.76 | 1 | Merz North America, Inc. ($12.76) |
| 2017 | $109.56 | 1 | Cook Incorporated ($109.56) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $39.70 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/05/2022 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $67.73 | General |
| Category: Pain Management | ||||||
| 10/05/2022 | Bioventus LLC | Stimrouter Implantable Kit (Device) | Food and Beverage | In-kind items and services | $44.03 | General |
| Category: Podiatry | ||||||
| 01/14/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/15/2021 | Boston Scientific Corporation | Superion (Device) | Food and Beverage | In-kind items and services | $96.91 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/24/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $12.76 | General |
| Category: MUSCULOSKELETAL | ||||||
| 09/21/2017 | Cook Incorporated | Cook Medical AAA (Device) | Food and Beverage | Cash or cash equivalent | $109.56 | General |
| Category: Aortic Intervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 841 | 2,047 | $473,538 | $99,590 |
| 2022 | 12 | 830 | 1,907 | $433,528 | $95,678 |
| 2021 | 14 | 911 | 1,203 | $363,588 | $94,068 |
| 2020 | 12 | 530 | 781 | $183,065 | $49,930 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 218 | $66,800 | $22,567 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 254 | $54,935 | $17,840 | 32.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 80 | 111 | $107,283 | $17,029 | 15.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 57 | 82 | $89,498 | $14,824 | 16.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 36 | 46 | $58,265 | $9,388 | 16.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $16,670 | $5,638 | 33.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 26 | 38 | $20,660 | $3,593 | 17.4% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 46 | 68 | $18,080 | $2,762 | 15.3% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 11 | 14 | $7,470 | $1,439 | 19.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $4,015 | $1,317 | 32.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 21 | $7,600 | $874.59 | 11.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 16 | 17 | $5,160 | $811.26 | 15.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 11 | 11 | $5,300 | $777.68 | 14.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 161 | 827 | $10,390 | $702.22 | 6.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 44 | 283 | $1,413 | $27.18 | 1.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 183 | $56,330 | $18,454 | 32.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 74 | 96 | $92,983 | $17,567 | 18.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 72 | 98 | $89,278 | $15,916 | 17.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 166 | $35,330 | $11,861 | 33.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 39 | 44 | $45,498 | $9,306 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $18,635 | $5,723 | 30.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 33 | 42 | $19,825 | $3,890 | 19.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 31 | 32 | $15,513 | $2,956 | 19.1% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 22 | 27 | $11,295 | $2,886 | 25.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 42 | 54 | $13,270 | $2,169 | 16.3% |
About Dr. Timothy Olson, M.D
Dr. Timothy Olson, M.D is a Interventional Pain Medicine healthcare provider based in Westerly, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558479261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Olson, M.D has received a total of $514.57 in payments from pharmaceutical and medical device companies, with $39.70 received in 2023. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($514.57).
As a Medicare-enrolled provider, Olson has provided services to 3,112 Medicare beneficiaries, totaling 5,938 services with total Medicare billing of $339,266. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Interventional Pain Medicine
- Location Westerly, RI
- Active Since 08/25/2006
- Last Updated 12/06/2018
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1558479261
Products in Payments
- TRELEGY ELLIPTA (Drug) $125.00
- Cook Medical AAA (Device) $109.56
- Superion (Device) $96.91
- Nalu Neurostimulation System (Device) $67.73
- Stimrouter Implantable Kit (Device) $44.03
- WaveWriter Alpha Prime 16 (Device) $39.70
- General - Pain Management (Device) $18.88
- XEOMIN (Biological) $12.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.